A recent study from the University of Southern California found that prices charged by hospitals in the Sutter Health system are about 25 percent higher than those of other hospitals in California. Ken James/Bloomberg via Getty Images hide caption

toggle caption
Ken James/Bloomberg via Getty Images

Big Hospital Network Cracks Down On The Right To Sue

  • Download
  • <iframe src="https://www.npr.org/player/embed/499146270/501053303" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Virginijus Siksnys' large research team at the Vilnius University Institute of Biotechnology in Lithuania. Arunas Silanskas/Vilnius University Institute of Biotechnology hide caption

toggle caption
Arunas Silanskas/Vilnius University Institute of Biotechnology

Science Rewards Eureka Moments, Except When It Doesn't

  • Download
  • <iframe src="https://www.npr.org/player/embed/500331130/500331131" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Community Health Options founders COO Robert Hillman (left) and CEO Kevin Lewis seen in 2013 when the co-op began offering coverage. Gordon Chibroski/Portland Press Herald/Getty Images hide caption

toggle caption
Gordon Chibroski/Portland Press Herald/Getty Images

After several prominent safety problems with medical devices in hospitals emerged, the Food and Drug Administration inspected 17 hospitals across the country in late 2015 to assess their compliance with reporting regulations. Congressional Quarterly/CQ-Roll Call, Inc./Getty Images hide caption

toggle caption
Congressional Quarterly/CQ-Roll Call, Inc./Getty Images

Shela Bryan of Hull, Ga., is looking for a new health insurance policy but has been stunned by the prices. Steven Bush/Courtesy of Shela Bryan hide caption

toggle caption
Steven Bush/Courtesy of Shela Bryan
Gary Waters/Ikon Images/Getty Images

Has The Human Life Span Hit The Ceiling?

  • Download
  • <iframe src="https://www.npr.org/player/embed/496532976/496755018" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Sarepta Therapeutics was awarded a voucher for a fast-track drug review by the Food and Drug Administration when the company's medicine for Duchenne muscular dystropy was approved Sept. 19. Now Sarepta is looking to sell the voucher to the highest bidder. Mick Wiggins/Ikon Images/Getty Images hide caption

toggle caption
Mick Wiggins/Ikon Images/Getty Images
John Labbe/Getty Images

Employees Are Paying A Bigger Chunk Of Health Insurance Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/493910307/493965938" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A screenshot from a video touting a gap plan called "Premium Saver." Screenshot by NPR/Crema Design Studio hide caption

toggle caption
Screenshot by NPR/Crema Design Studio

Would You Like Some Insurance With Your Insurance?

Audio for this story is unavailable.

Cassie Ray (seen with her husband, Gerry) got a surprise bill from an out-of-network anesthesiologist after an operation. Courtesy of Cassie Ray hide caption

toggle caption
Courtesy of Cassie Ray

California Aims To Limit Surprise Medical Bills

  • Download
  • <iframe src="https://www.npr.org/player/embed/493233748/493491977" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Where are the generic alternatives to EpiPen and other expensive drugs that have lost patent protection? Victor J. Blue/Bloomberg via Getty Images hide caption

toggle caption
Victor J. Blue/Bloomberg via Getty Images

Mylan, the maker of EpiPen, says it will sell a generic version for $300 for a two-pack, a price that consumer advocates say is still too high. The device is used to treat severe allergic reactions. Daniel Acker/Bloomberg via Getty Images hide caption

toggle caption
Daniel Acker/Bloomberg via Getty Images

Maker Of EpiPen To Sell Generic Version For Half The Price

  • Download
  • <iframe src="https://www.npr.org/player/embed/491797051/491848114" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Careful audits of a representative sampling of bills from 37 Medicare Advantage Programs in 2007 have revealed some consistent patterns in the way they overbill, a Center for Public Integrity investigation finds. Nick Shepherd/Ikon Images/Getty Images hide caption

toggle caption
Nick Shepherd/Ikon Images/Getty Images

The cost of an EpiPen two-pack has risen more than 400 percent in recent years. The drug is used to halt severe allergic reactions. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images

Discounts Aren't Enough to Halt Outrage At High EpiPen Prices

  • Download
  • <iframe src="https://www.npr.org/player/embed/491372193/491390054" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript